Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-016088

Director acquired 8,876 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Reasons Bryan M. Director 2020-03-02 Option exercise +8,876 8,876 D
Derivatives
Reasons Bryan M. Director 2020-03-02 Grant or award · Restricted stock units +8,876 8,876 D
Reasons Bryan M. Director 2020-03-02 Option exercise · Restricted stock units −8,876 0 D
Loading xslF345X03/doc4.xml…